Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development...
48 KB (3,857 words) - 10:50, 30 July 2024
Biogen (UK) Ltd is a leading UK owner and operator of anaerobic digestion and composting plants based in Bedfordshire. It is responsible for the construction...
5 KB (499 words) - 14:02, 26 January 2024
people with Alzheimer's disease to reduce its buildup. It was developed by Biogen and Eisai. Aducanumab is given via intravenous infusion. Aducanumab was...
61 KB (4,888 words) - 07:49, 4 July 2024
funded by Cure SMA. Starting in 2012, Ionis partnered with Biogen on development and, in 2015, Biogen acquired an exclusive license to the drug for a US$75...
27 KB (2,095 words) - 07:27, 1 July 2024
esters, primarily dimethyl fumarate, and marketed as Fumaderm by Biogen Idec in Europe. Biogen would later go on to develop the main ester, dimethyl fumarate...
12 KB (963 words) - 13:59, 27 July 2024
developed by Ionis Pharmaceuticals and was licensed to, and co-developed by, Biogen. The effectiveness of tofersen was evaluated in a 28-week, randomized, double-blind...
12 KB (854 words) - 02:59, 15 June 2024
2016 Biogen announced that it would spin off its hemophilia drug business (Eloctate and Alprolix) into a separate public company. In August, Biogen announced...
7 KB (469 words) - 14:03, 8 August 2024
from 2017 to 2023. Scangos was previously the chief executive officer of Biogen from 2010 to 2016 and of Exelixis from 1996 to 2010. Prior to joining industry...
8 KB (678 words) - 07:35, 13 February 2024
conducted by Fumapharm in collaboration with Biogen Idec; Fumapharm was subsequently acquired by Biogen Idec in 2006. Aditech Pharma in Sweden had also...
30 KB (2,897 words) - 14:05, 20 July 2024
merged with Biogen to form the third largest biotech firm in the United States. Rastetter was Executive Chair of the new company, Biogen IDEC, from 2003...
28 KB (2,547 words) - 23:16, 16 July 2024